Literature DB >> 10608033

A Noninvasive Approach for the Treatment of Patients with Suspected Pulmonary Embolism.

.   

Abstract

The diagnosis of pulmonary embolism is challenging because the signs and symptoms are nonspecific, the findings on ventilation-perfusion lung scans are often nondiagnostic, and pulmonary angiography, although definitive, is not always available. We previously reported that serial noninvasive leg testing provided a practical, noninvasive alternative to pulmonary angiography in patients who had nondiagnostic lung scans and adequate cardiorespiratory reserve. In this prospective cohort study of 1564 patients with suspected pulmonary embolism, ventilation-perfusion lung scanning and serial impedance plethysmography were used to objectively assess prognosis. Only 12 of 627 patients (1.9%) with nondiagnostic lung scans but normal serial leg testing results who were not given anticoagulants had venous thromboembolism during long-term follow-up. Noninvasive serial leg testing can avoid the need for pulmonary angiography for the majority of patients, identify those with proximal vein thrombosis who require anticoagulant treatment, and avert treatment and further investigation of patients who have adequate cardiorespiratory reserve.

Entities:  

Year:  1996        PMID: 10608033     DOI: 10.1007/bf00226403

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  12 in total

1.  A new noninvasive management strategy for patients with suspected pulmonary embolism.

Authors:  R D Hull; G E Raskob; G Coates; A A Panju; G J Gill
Journal:  Arch Intern Med       Date:  1989-11

2.  Lung scan interpretation: a physiologic, user-friendly approach.

Authors:  A Gottschalk
Journal:  J Nucl Med       Date:  1992-07       Impact factor: 10.057

3.  Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting.

Authors:  M V Huisman; H R Büller; J W ten Cate; H S Heijermans; J van der Laan; D J van Maanen
Journal:  Arch Intern Med       Date:  1989-03

4.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Authors:  R D Hull; G E Raskob; J Hirsh; R M Jay; J R Leclerc; W H Geerts; D Rosenbloom; D L Sackett; C Anderson; L Harrison
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

5.  Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients.

Authors:  H Heijboer; A Cogo; H R Büller; P Prandoni; J W ten Cate
Journal:  Arch Intern Med       Date:  1992-09

6.  The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.

Authors:  R D Hull; C J Carter; R M Jay; P A Ockelford; J Hirsch; A G Turpie; A Zielinsky; M Gent; P J Powers
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

7.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

Authors: 
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

8.  Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.

Authors:  D P Brandjes; H Heijboer; H R Büller; M de Rijk; H Jagt; J W ten Cate
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

9.  Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.

Authors:  R Hull; T Delmore; E Genton; J Hirsh; M Gent; D Sackett; D McLoughlin; P Armstrong
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

10.  A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.

Authors:  H Heijboer; H R Büller; A W Lensing; A G Turpie; L P Colly; J W ten Cate
Journal:  N Engl J Med       Date:  1993-11-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.